Neuroscientific Biopharmaceuticals Ltd - Asset Resilience Ratio

Latest as of December 2025: 38.16%

Neuroscientific Biopharmaceuticals Ltd (NSB) has an Asset Resilience Ratio of 38.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check NSB capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$6.36 Million

≈ $4.50 Million USD Cash + Short-term Investments

Total Assets

AU$16.66 Million

≈ $11.79 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Neuroscientific Biopharmaceuticals Ltd's Asset Resilience Ratio has changed over time. See Neuroscientific Biopharmaceuticals Ltd net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NSB stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$1.11 Million	6.65%
Short-term Investments	AU$5.25 Million	31.51%
Total Liquid Assets	AU$6.36 Million	38.16%

Asset Resilience Insights

Very High Liquidity: Neuroscientific Biopharmaceuticals Ltd maintains exceptional liquid asset reserves at 38.16% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Neuroscientific Biopharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Neuroscientific Biopharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
BB Biotech AG SW:BION	Biotechnology	0.05%
Concord Biotech Limited NSE:CONCORDBIO	Biotechnology	18.00%
Pharming Group NV AS:PHARM	Biotechnology	7.13%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Clarity Pharmaceuticals Ltd AU:CU6	Biotechnology	73.99%
Yantai Zhenghai Bio-Tech Co Ltd SHE:300653	Biotechnology	56.48%

Annual Asset Resilience Ratio for Neuroscientific Biopharmaceuticals Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Neuroscientific Biopharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	42.83%	AU$7.27 Million ≈ $5.14 Million	AU$16.96 Million ≈ $12.00 Million	-48.30pp
2024-06-30	91.14%	AU$4.95 Million ≈ $3.51 Million	AU$5.44 Million ≈ $3.85 Million	-1.69pp
2023-06-30	92.83%	AU$4.91 Million ≈ $3.48 Million	AU$5.29 Million ≈ $3.74 Million	-0.43pp
2022-06-30	93.26%	AU$7.22 Million ≈ $5.11 Million	AU$7.74 Million ≈ $5.47 Million	-2.25pp
2021-06-30	95.51%	AU$14.16 Million ≈ $10.02 Million	AU$14.83 Million ≈ $10.49 Million	+7.58pp
2020-06-30	87.94%	AU$3.29 Million ≈ $2.33 Million	AU$3.74 Million ≈ $2.64 Million	-2.04pp
2019-06-30	89.97%	AU$4.61 Million ≈ $3.26 Million	AU$5.12 Million ≈ $3.63 Million	--

pp = percentage points

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$14.59 Million

AU$20.62 Million AUD

Market Cap Rank

#26082 Global

#1182 in Australia

Share Price

AU$0.06

Change (1 day)

-6.06%

52-Week Range

AU$0.06 - AU$0.25

All Time High

AU$0.52